UPDATE: Oppenheimer Downgrades IDEX Corp (IEX) to Perform on Valuation
Get Alerts IEX Hot Sheet
Price: $240.56 --0%
Rating Summary:
14 Buy, 14 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 36
Rating Summary:
14 Buy, 14 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 36
Join SI Premium – FREE
(Updated - October 2, 2012 11:03 AM EDT)
Oppenheimer downgraded IDEX Corp (NYSE: IEX) from Outperform to Perform.
"While longer term prospects for the company remain upbeat, we believe sources of revenue-driven earnings upside are limited near term," the analyst comments. "We believe investors are more apt to reward attractive organic growth trends and prospects rather than gains from cost controls or share repurchases in the near term. Additionally, recent strength in the shares has lifted IEX to our price target, a valuation close to its 5-year average P/E of 15x, rendering risk/reward more balanced, in our view."
For an analyst ratings summary and ratings history on IDEX Corp click here. For more ratings news on IDEX Corp click here.
Shares of IDEX Corp closed at $41.70 yesterday.
Oppenheimer downgraded IDEX Corp (NYSE: IEX) from Outperform to Perform.
"While longer term prospects for the company remain upbeat, we believe sources of revenue-driven earnings upside are limited near term," the analyst comments. "We believe investors are more apt to reward attractive organic growth trends and prospects rather than gains from cost controls or share repurchases in the near term. Additionally, recent strength in the shares has lifted IEX to our price target, a valuation close to its 5-year average P/E of 15x, rendering risk/reward more balanced, in our view."
For an analyst ratings summary and ratings history on IDEX Corp click here. For more ratings news on IDEX Corp click here.
Shares of IDEX Corp closed at $41.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades Veradigm Inc (MDRX) to Hold
- Adverum Biotechnologies (ADVM) Tops Q4 EPS by 11c
- Augmedix, Inc. (AUGX) Tops Q4 EPS by 1c
Create E-mail Alert Related Categories
DowngradesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!